Stockreport

Novartis to Acquire Tourmaline Bio in $1.4 Billion Deal [Yahoo! Finance]

Tourmaline Bio, Inc.  (TRML) 
PDF Novartis ( NOVN Financials ) said Tuesday it will acquire Tourmaline Bio in a $1.4 billion deal as it looks to strengthen its cardiovascular disease portfolio. Is XSW [Read more]